Dennis J. Slamon
For the development of targeted therapy Herceptin against advanced breast cancer expressing the Her-2/Neu oncogene resulting in more effective therapy for breast cancer.
La reconnaissance d'un travail ayant un impact durable
For the development of targeted therapy Herceptin against advanced breast cancer expressing the Her-2/Neu oncogene resulting in more effective therapy for breast cancer.